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Abstract
Objective: Progesterone (P4) has been clinically shown
to prevent the recurrence of preterm birth. The mecha-
nism(s) of action is unclear, but may involve modulation
of the immunologic inflammatory response of the lower
genital tract. We evaluated the effects of P4 on interleu-
kin-8 (IL-8) production by vaginal and cervical epithelial
cells stimulated with bacterial species that are commonly
associated with preterm birth.
Methods: Vaginal and endocervical epithelial cells were
incubated with up to 10,000 ng/mL P4 overnight and
stimulated with heat-killed Escherichia coli, Gardnerella
vaginalis, or Ureaplasma urealyticum. Concentrations of
IL-8 in conditioned medium were quantified by ELISA
and viability of the cell cultures was measured by the
reduction of a tetrazolium salt.
Results: E. coli, G. vaginalis and U. urealyticum-stimu-
lated IL-8 production for both cell lines. P4 inhibited basal
and bacteria-stimulated IL-8 production for vaginal epi-
thelial cells but enhanced IL-8 production by endocervi-
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cal cells. P4 reduced the number of viable cells for both
cell lines.
Conclusions: P4 inhibits IL-8 production by vaginal epi-
thelial cells stimulated with pathogens associated with
preterm birth, possibly by reducing the number of viable
cells or by inhibiting their proliferation. Although P4 also
reduces proliferation of endocervical cells it also increas-
es their production of IL-8.
Keywords: Infection; innate immunity; preterm birth;
progesterone; vaginal immunity.
Introduction
Supplemental progesterone or progestin (P4) has been
shown to prevent recurrent preterm birth in several clin-
ical trials w6, 19, 22x, however, the mechanism by which
P4 functions to prevent preterm birth remains unclear.
Two recent studies have suggested that supplemental P4
via vaginal suppositories prevents preterm birth in wom-
en with a short cervix w7, 13x and may also improve neo-
natal outcomes by reducing both admissions and lengths
of stay at the neonatal intensive care unit w7x. In fact, P4
had no significant effect on preterm birth in women with
cervical lengths )28 mm. These studies suggest that
the lower genital tract may be a target tissue for this
hormone.
Many spontaneous preterm births are thought to be
the end result of infections that ascend from the vagina
through the cervix and become established in the upper
genital tract. Bacterial products such as lipopolysaccha-
ride (LPS) increase interleukin (IL)-8 production by cer-
vical cells w29x. Aberrantly high concentrations of IL-8 in
cervical-vaginal fluids have previously been correlated
with preterm birth and chorioamnionitis w17x and both IL-
8 and LPS have been shown to induce cervical ripening
in animal models w5, 8, 9x. Premature cervical ripening
could potentially permit bacteria to ascend into the upper
genital tract where they can stimulate a preterm labor
response. We therefore hypothesized that P4 may prevent
preterm birth by inhibiting bacteria-stimulated IL-8 pro-
duction by cells of the lower genital tract. To test the
biologic principle underlying this hypothesis, we used an
in vitro model to test whether P4 can alter IL-8 production
by vaginal and endocervical cells exposed to bacterial
pathogens commonly associated with infection-mediat-
ed preterm birth.
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Materials and methods
Cell lines and bacterial cultures
Vaginal (VK2E6E7) and endocervical epithelial cells (ENDE6E7)
were purchased from ATCC (Manassas, VA) for utilization in this
experiment. These cell lines were produced from primary cul-
tures isolated from non-pregnant subjects and immortalized by
in vitro infection with human papilloma virus 16 and retain many
characteristics of primary cells in terms of keratin expression
w10x. Therefore, the responses of these cells are probably more
physiological than other cell lines. Cells were propagated in
keratinocyte serum-free (KSM) medium and split at 70–90%
confluence by trypsinization. Stock reference cultures of Esche-
richia coli, Gardnerella vaginalis, Ureaplasma urealyticum (U.
urealyticum serotype 1-now reclassified as U. parvum) were also
purchased from ATCC. E. coli and G. vaginalis were cultivated
as directed. U. urealyticum was cultivated in beef heart infu-
sionq20% horse serumq10% Yeast extract dialysateq1 g/L
ureaq20 mg/L phenol red. Organisms were harvested by
centrifugation at 10,000 g and re-suspended in KSFM or RPMI
1640. The number of colony forming U/mL was then determined
for E. coli or G. vaginalis by plating serial dilutions on the appro-
priate agar. Re-suspended cultures of U. urealyticum were quan-
tified by measuring the color changing units (CCU), defined as
the lowest 10-fold dilution that causes a color change (indicating
growth) in the broth above. Bacteria were heat-killed by heating
at 808C for 1 h and aliquots of the heat-killed bacteria were
stored at –708C until use. This is a standard method of preparing
bacteria for in vitro experiments to test cellular immune
responses to bacterial components (live bacteria divide rapidly
and would quickly overgrow the mammalian cells in culture).
Cell cultures
Freshly split cells (diluted 1:4 after trypsinization) were plated on
96-well plates in 160 mL medium and permitted to adhere over-
night in a humidified incubator at 378C in a 5% CO2 (v/v) atmo-
sphere. P4 treatments were then added to final concentration
(0–10,000 ng/mL) in a volume of 20 mL KSMq10% fetal bovine
serumq1% Dimethyl sulfoxide and cultures were incubated
overnight as described above. Cells were then stimulated by
adding heat-killed bacteria or an equivalent volume (20 mL) of
vehicle and returned to the incubator for a final overnight incu-
bation. A harvest of 100 mL of the conditioned medium was
stored at –708C until assay for IL-8 by ELISA using reagents
purchased from R and D systems (Minneapolis, MN). Potential
effects of P4 on number of viable cells was evaluated using the
MTT assay as previously described w25x. Briefly, 20 mL tetra-
zolium salt (5 mg/mL) was incubated for 2 h at 378C. Formosan
crystals formed by live cells were then dissolved by adding
100 mL 10% SDSq0.01 M HCl to each well and incubating the
plate at 378C overnight. Optical density at 570 and 690 nm was
quantified on a microplate spectrophotometer and data are
expressed as OD570–690, which is directly proportional to the
relative number of live cells.
Statistical analyses
Data were analyzed using the general linear models procedure
of SAS (SAS Institute, Cary, NC) for a randomized block design.
Effects due to experiment were considered random and all
others fixed. Results are reported as least-square means with
accompanying asymptotic standard errors. Data from each
experiment were evaluated for deviations from the assumptions
of least-squares techniques (normality, equality, and independ-
ence of errors). When violations of the assumptions of ANOVA
were detected, data were transformed using the Box-Cox algo-
rithm w23x. Analyses from the transformed data were used for
hypothesis testing (P-values). All data presented are from the
untransformed dataset for clarity of presentation. IL-8 concen-
trations were not adjusted for confounding by viability of the cell
cultures due to the possibility that any observed changes in IL-
8 production may be caused by changes in the number of viable




IL-8 production by vaginal epithelial cells was signifi-
cantly increased upon stimulation with 108 CFU/mL
E. coli (1418.47"454.03 vs. 6031.53"454.03 pg/mL;
control vs. stimulated cells; Ps0.0116), 2=106 CFU
G. vaginalis (1324.06"149.80 vs. 2991.49"149.80
pg/mL; Ps0.0024) or 11 CCU U. urealyticum (2270.02"
429.25 vs. 14028.89"429.25 pg/mL; Ps0.0036). P4
significantly decreased IL-8 production by cultures stim-
ulated with these pathogens as well as unstimulated cells
but only at the highest concentration (10,000 ng/mL)
tested (Figure 1). At this concentration, P4 also signifi-
cantly reduced the number of viable cells for unstimulat-
ed cultures (P-0.001) as well as those treated with E.
coli (P-0.001), G. vaginalis (P-0.001) or U. urealyticum
(P-0.001).
Endocervical cells
IL-8 production by endocervical cells was slightly
enhanced by stimulation with E. coli (2129.34"88.10 vs.
2946.65"88.10 pg/mL; control vs. treated; Ps0.0286),
G. vaginalis (2296.85"120.74 vs. 5378.50"120.74
pg/mL; Ps0.0154), or U. urealyticum (1920.23"166.43
vs. 3288.87"166.43 pg/mL; Ps0.0668). Both basal and
bacteria-stimulated IL-8 production was enhanced by P4
in a dose-dependent manner, however, results were only
significant for cultures treated with very high doses of
1000 and 10,000 pg/mL P4 (Figure 2). As with vaginal
epithelial cells, the number of viable cells was reduced
by 1000–10,000 pg/mL P4 (Figure 2).
Discussion
We found that E. coli, G. vaginalis and U. urealyticum
increase the production of IL-8 by both vaginal and cer-
vical epithelial cells. This is consistent with previous stud-
ies which reported that Neisseria gonorrhoeae induce the
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Figure 1 P4 decreases bacteria-stimulated IL-8 production by vaginal epithelial cells. Vaginal epithelial cells were treated with
0–10,000 ng/mL P4 overnight and then stimulated with 108 CFU/mL heat-killed E. coli for, 2=106 CFU/mL G. vaginalis or 11 CCU of
U. urealyticum or an equivalent volume of sterile medium (unstimulated cells) in separate experiments. Shown are least-squares
means"SEM for IL-8 production (left panels) and relative number of viable cells as determined by the MTT assay (right panels).
Points marked with an asterisk(s) are significantly different from 0 ng/mL P4 for that bacterial treatment (*P-0.05; **P-0.01;
***P-0.0001).
production of proinflammatory chemokines by these cell
lines w12x. Clinical studies have also shown an associa-
tion with increased IL-8 levels in vaginal lavage of women
with genital mycoplasmas compared with normal flora
w28x. IL-8 levels in vaginal fluid are also positively corre-
lated with concentrations of IgA to G. vaginalis hemolysin
w2x which is consistent with our results.
In general, we found that P4 significantly decreased
bacteria-stimulated IL-8 production by vaginal epithelial
cells for all pathogens studied as well as for cultures not
treated with bacteria. This immunosuppressive effect is
consistent with the observation that progesterone
enhances the establishment of infections with Mycoplas-
ma pulmonis w15x, M. pneumoniae w14, 15x, M. genitalium
w15x, Chlamydia w20x and herpes simplex virus w16x in ani-
mal models. Part of the mechanism for P4-immunomo-
dulation of bacteria-stimulated IL-8 production may
involve effects on viability or proliferation of the vaginal
epithelial cells. High concentrations of P4 consistently
lowered the number of viable vaginal epithelial cells
regardless of whether or not pathogens were present.
This is consistent with previous studies that reported
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Figure 2 Effect of P4 on bacteria-stimulated IL-8 production by endocervical epithelial cells. Cells were incubated with 0–10,000
ng/mL P4 overnight and then left unstimulated or treated with heat-killed E. coli, G. vaginalis or U. urealyticum. Shown are results
pooled for 3–9 separate experiments.
reductions of vaginal epithelium thickness in vivo by P4
w24x.
Previous studies demonstrated that P4 can suppress
IL-8 production in the rabbit cervix w18x, therefore, we
hypothesized that high concentrations of P4 may block
bacteria-stimulated increases in IL-8 production that, in
turn, may prevent premature cervical ripening and its
consequences, including preterm birth. Contrary to our
expectation, however, we found that P4 increases basal
and bacteria-stimulated production of IL-8 by endocer-
vical cells. These results differ from those of a previous
report where P4 had no effect on basal or phorbol ester-
stimulated IL-8 production by cervical explants from non-
pregnant women w1x. The difference between these
results may be due to the concentrations of P4 used to
treat the cultures. Barclay et al. used 1 mM P4 which is
equivalent to 314.5 ng/mL. We tested P4 at concentra-
tions of up to 10,000 ng/mL which were supraphysiolo-
gical because concentrations in the term placenta are
only about 2000–3000 ng/g tissue w21x. It is likely how-
ever, that the concentration used in our in vitro study are
still lower than what would be present in the lower genital
tract after intravaginal placement of 90–200 mg P4 as
was done in the two protocols demonstrating P4’s effec-
tiveness at preventing preterm birth in women with a
short cervix w7, 13x.
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Although we found that high levels of P4 enhance rath-
er than inhibit IL-8 production in the cervix, recent evi-
dence suggests that a small increase in IL-8 could be
beneficial in preventing preterm birth. Asymptomatic
women who later go on to develop intra-amniotic infec-
tion had lower levels of IL-8, IL-1b and IL-6 in the cervix
compared to women who did not w27x. It is proposed that
the lower levels of cytokines resulted in hypo-respon-
siveness to bacteria and enabled infections to become
more easily established in the cervix and to ascend into
the upper genital tract w27x. A slight enhancement of IL-
8 production and perhaps other proinflammatory medi-
ators by P4 in the cervix may help to clear infections
before they become established in the cervix and trigger
a much more robust IL-8 response that causes a massive
host response that results in cervical ripening and pre-
term birth.
Our finding that P4 decreased the number of viable
endocervical cells suggests that augmentation of IL-8
levels is not due to any proliferative effect of P4 on the
cells. Although fewer endocervical cells are present in
P4-treated cultures, it is likely that they could still produce
more IL-8 upon stimulation with bacteria if IL-8 produc-
tion in each cell was increased enough to compensate
for the 20% fewer live cells that are present. Although it
is possible that high concentrations of P4 are toxic to
cells, it is more likely that this hormone reduces their pro-
liferation. A previous study reported that injection of
medroxyprogesterone decreases DNA synthesis in the
rabbit endocervix w3x. P4 may do this by lowering the
expression of the epithelial growth factor receptor on
endocervical cells w4x. A small amount (0.1 ng/mL) of epi-
dermal growth factor in the medium is required for the
cultivation of these cells w11x and P4-mediated reductions
in the EGF receptor may inhibit the proliferation of these
cells as well.
Although a number of other cytokines are increased
during cervical ripening, we chose to focus on IL-8 for
several reasons. First, our preliminary studies demon-
strated that the cell lines responded most robustly to
bacterial stimulation with this cytokine. Second, IL-8 is a
chemoattractant and activator of neutrophils which are
recruited to the cervix during ripening. IL-8 levels are
positively correlated with granulocyte elastase levels in
the cervix w26x. Third, placement of IL-8 into the cervix
causes ripening in animal models w5, 9x. Although other
proinflammatory cytokines such as TNF-a and IL-1b are
increased in the cervix during cervical ripening, these
cytokines also induce the production of IL-8 by endo-
cervical cells w9x. Therefore, their biological activity for
promoting cervical ripening may be mediated, at least in
part, through IL-8 production. Genetic knock-out mice
for many proinflammatory cytokines such as IL-1b, TNF-
a, and MCP-1 are available and we are unaware of any
defects in cervical ripening in such animals. Therefore,
we chose to study IL-8 as a model cytokine for the host-
immune response, and to test variety of species of bac-
teria containing different virulence factors rather than a
variety of cytokines and chemokines that would be highly
correlated with one another.
Our results are also limited by several factors that are
inherent to in vitro experiments with transformed cell
lines. For example, we are unable to account for the
impact that other maternal or fetal hormones or cell types
in the lower genital tract may have had on the ability for
P4 to modulate IL-8 concentrations in the cervix or the
vagina. We are also unable to determine what exposure
to P4 over the course of many weeks may have on the
responsiveness of cells to bacteria. Furthermore, immune
responses to a live, growing culture of bacteria in vivo
may be markedly different from those generated by stim-
ulation of cells with heat-killed organisms. These limita-
tions could partially be overcome by quantifying cervical
levels of IL-8, and bacteria in clinical samples from wom-
en taking supplemental progesterone. It would be very
difficult now, however, to get samples from a control
group with similar reproductive histories since the use of
this hormone for preventing preterm birth is now wide-
spread. It would also be difficult to interpret how cervical
cytokines respond to bacterial pathogens in women in
vivo when the vaginal flora is complex and consists of
many different species. In contrast, our study with trans-
formed cells enabled to study many different treatments
under carefully controlled conditions with human cells
which would not be possible in a clinical setting.
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